Alkermes Announces Positive Results from Phase 1 Study of ALKS 33 in Combination with Buprenorphine for Treatment of …

Published October 31, 2010

Alkermes Announces Positive Results from Phase 1 Study of ALKS 33 in Combination with Buprenorphine for Treatment of …
Alkermes, Inc. today announced positive topline results from a phase 1 clinical study of an investigational combination of ALKS 33, one of Alkermes’ proprietary candidates, and buprenorphine, an existing medication for the treatment of opioid addiction, for the treatment of cocaine addiction.
Read more on Business Wire via Yahoo! Finance

New Vision
New Vision
Read more on Atlanta Journal-Constitution

Experts: Exhaustion can be a valid medical condition
For many of us, exhaustion is a fact of life. But for the rich and famous, it seems acute weariness can be so debilitating that it requires hospitalization. read more
Read more on Standard-Examiner